Agenda
Times listed are for Eastern Daylight Savings Time.
Posters will be available for viewing from 8 AM starting on Monday through the end of the meeting on Wednesday. Virtual interactive Poster Sessions are scheduled from 3:30 to 6:00 PM on Monday and Tuesday evenings.
Day 1 (11:00 AM to 6:00 PM)
| 10:45-11:00 AM |
Welcome Mark Miller, Ph.D., Meeting Co-Organizer, DCP/NCI Altaf Mohammed, Ph.D., Meeting Co-Organizer, DCP/NCI |
| 11:00-12:00 PM |
Plenary Talk Steven Lipkin, M.D., Ph.D., Weill Cornell Medicine The CAP-IT Center for LNP RNA Immunoprevention |
| Session I: Molecularly Targeted Novel Agents and Emerging Technologies for Preventative Agent Development Research | |
|---|---|
| Co-Chairs: Margie Clapper, Ph.D. and John Clifford, Ph.D. | |
| 12:00-12:30 PM |
Speaker 1: Margie Clapper, Ph.D., Fox Chase Cancer Center Modulation of Estrogen Metabolism as a Strategy for the Early Interception of Non-Small Cell Lung Cancer |
| 12:30-1:00 PM |
Speaker 2: Chinthalapally V. Rao, Ph.D., Oklahoma University Health Sciences Center Interception of CRC Progression in FAP Rat Model Using a Combinational Targeting of TRAIL Signaling and Inflammation |
| 1:00-1:30 PM |
Lunch |
| 1:30-2:00 PM |
Speaker 3: Fan Zhang, Ph.D., College of Pharmacy, University of Florida Health Tuning the Organ-Selectivity of mRNA Expression through Dendrimer-Based Lipid Nanoparticles |
| 2:00-2:30 PM |
Speaker 4: Pratip Bhattacharya, Ph.D., MD Anderson Cancer Center Real-time Hyperpolarized Metabolic Imaging for Early Detection and Prevention of Pancreatic Cancer |
| 2:30-2:45 PM |
Flash Talk 1: TBD |
| 2:45-3:00 PM |
Flash Talk 2: TBD |
| 3:00-3:30 PM |
Break |
| 3:30-6:00 PM |
Interactive Poster Session (Posters 1-15) Breakout Sessions with NCI Program Staff Meet the Expert Session |
| Adjourn (Posters remain available for viewing | |
Day 2 Sessions (11:00 AM to 6:00 PM)
| Session II: Emerging Vaccines and Immunomodulatory Agents for Cancer Prevention | |
|---|---|
| Co-Chairs: Catherine J. Wu, M.D. and Shizuko Sei, M.D. | |
| 11:00-11:30 AM |
Speaker 1: Catherine J. Wu, M.D., Dana Farber Cancer Institute Updates on Personalized Cancer Vaccines
|
| 11:30-12:00 PM |
Speaker 2: Madhav Dhodapkar, M.B.S.S, Emory University Targeting Underlying Triggers and Spatial Immunology Towards Cancer Prevention |
| 12:00-12:30 PM |
Speaker 3: Vinod P. Balachandran, M.D., Memorial Sloan Kettering Cancer Center Personalized RNA Vaccines for Pancreatic Cancer |
| 12:30-1:00 PM |
Speaker 4: Steven Reed, Ph.D., HDTBio RNA Vaccines for Cancer: Overcoming Challenges |
| 1:00-1:30 PM |
Speaker 5: Barbara Vanderhyden, Ph.D., University of Ottawa Targeting Age-Associated Ovarian Fibrosis to Reduce Cancer Risk |
| 12:00-1:00 PM | Lunch |
| Session III: NCI Resources Session | |
| 2:00-2:30 PM |
Altaf Mohammed, Ph.D., Program Director, DCP/NCI CIP-Net Cooperative Grant Program |
| 2:30-3:00 PM |
Mark Miller, Ph.D., Director of PREVENT Operations, DCP/NCI PREVENT Agent Development Pipeline |
| 3:00-3:30 PM |
Break |
| 3:30-6:00 PM |
Interactive Poster Session (Posters 16-30) Breakout Sessions with NCI Program Staff Meet the Expert Session |
| Adjourn (Posters remain available for viewing) | |
Day 3 Session (11:00 AM to 2:30 PM)
| Session IV: Navigating Prevention Trials: Challenges and Opportunities | |
|---|---|
| Co-Chairs: Ajay Bansal, M.D. and Howard Parnes, M.D. | |
| 11:00-11:30 AM |
Speaker 1: Eva Szabo, M.D., DCP/NCI Overview of DCP Supported Clinical Trials
|
| 11:30-12:00 PM |
Speaker 2: Shadmehr Demehri, M.D., Ph.D., Massachusetts General Hospital Topical Immunotherapy for Skin Cancer Prevention in Organ Transplant Recipients |
| 12:00-12:30 PM |
Speaker 3: Ajay Bansal, M.D., University of Kansas Multivalent Vaccines boosted by IL-15 Superagonist for Cancer Interception in Lynch Syndrome: A Phase IIb Trial |
| 12:30-1:00 PM |
Lunch |
| 1:00-1:30 PM |
Speaker 4: Julie Bauman, M.D., M.P.H., George Washington University Cancer Center Green Chemoprevention of Environmental Carcinogenesis: Lessons From The Field |
| 1:30-2:00 PM |
Speaker 5: Adetunji T. Toriola, M.D., Ph.D., MPH, University of Washington at St. Louis Targeting RANKL Signaling in Premenopausal Women with Dense Breasts |
| 2:00-2:30 PM |
Speaker 6: Peter Allen, M.D., Duke University Progress Report on the Prevention of Progression to Pancreatic Cancer (3P-C) Trial |
|
Closing Remarks and Adjourn Mark Miller, Ph.D., Meeting Co-Organizer, DCP/NCI Altaf Mohammed, Ph.D., Meeting Co-Organizer, DCP/NCI |
|